Anti-Interleukin 23 Biologic Are Mostly Effective and Safe in Psoriatic Patients Who Failed Anti-Interleukin 17. A Real-Life, Retrospective 52-Week Experience

Saved in:
Bibliographic Details
Published inActas dermo-sifiliograficas Vol. 114; no. 4; pp. 363 - 365
Main Authors Arroyo-Andrés, J, Falkenhain-López, D, Agud-Dios, M, Rivera-Díaz, R
Format Report
LanguageEnglish
Spanish
Published 01.04.2023
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Case Study-2
content type line 59
SourceType-Reports-1
ObjectType-Report-1
ISSN:1578-2190
DOI:10.1016/j.ad.2022.05.035